References
- World Health Organization, International Spinal Cord Society. International Perspectives on Spinal Cord Injury. Malta: World Health Organization, International Spinal Cord Society; 2013.
- Sezer N, Akkuş S, Uğurlu FG. Chronic complications of spinal cord injury. World J Orthop. 2015;6(1):24–33.
- Adriaansen JJ, Ruijs LE, van Koppenhagen CF, et al. Secondary health conditions and quality of life in persons living with spinal cord injury for at least ten years. J Rehabil Med. 2016;48(10):853–860.
- Brinkhof MW, Al-Khodairy A, Eriks-Hoogland I, et al. Health conditions in people with spinal cord injury: contemporary evidence from a population-based community survey in Switzerland. J Rehabil Med. 2016;48(2):197–209.
- LaVela SL, Weaver FM, Goldstein B, et al. Diabetes mellitus in individuals with spinal cord injury or disorder. J Spinal Cord Med. 2006;29(4):387–395.
- Cragg JJ, Noonan VK, Krassioukov A, et al. Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology. 2013;81(8):723–728.
- Hand BN, Krause JS, Simpson KN. Dose and duration of opioid use in propensity score–matched, privately insured opioid users with and without spinal cord injury. Arch Phys Med Rehabil. 2018;99(5):855–861.
- Patel T, Milligan J, Lee J. Medication-related problems in individuals with spinal cord injury in a primary care-based clinic. J Spinal Cord Med. 2017;40(1):54–61.
- Kitzman P, Cecil D, Kolpek JH. The risks of polypharmacy following spinal cord injury. J Spinal Cord Med. 2017;40(2):147–153.
- Lee AK, Miller WC, Townson AF, F2N2 Research Group, et al. Medication use is associated with fatigue in a sample of community-living individuals who have a spinal cord injury: a chart review. Spinal Cord. 2010;48(5):429–433.
- Nelson AD, Camilleri M. Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Therap Adv Gastroenterol. 2015;8(4):206–220.
- Guilcher SJT, Hogan M-E, Calzavara A, et al. Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada. Spinal Cord. 2018;56(11):1059–1068.
- Jensen EK, Biering-Sorensen F. Medication before and after a spinal cord lesion. Spinal Cord. 2014;52(5):358–363.
- Doan J, Zakrzewski-Jakubiak H, Roy J, et al. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013;47(3):324–332.
- Nikolaus T, Kruse W, Bach M, et al. Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996;49(4):255–259.
- Guilcher SJT, Everall AC, Patel T, et al. Medication adherence for persons with spinal cord injury and dysfunction from the perspectives of healthcare providers: a qualitative study. J Spinal Cord Med. 2019;42(sup1):215–225.
- Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure-A register-based study in Sweden 2005–2009. Health Policy. 2013;109(2):166–174.
- Lu WH, Lee WJ, Chen LK, et al. Comparisons of annual health care utilization, drug consumption, and medical expenditure between the elderly and general population in Taiwan. J Clin Gerontol Geriatr. 2016;7(2):44–47.
- Canadian Pharmacists Association. 2019. [cited 2020 Jul 22]. Available from: https://www.pharmacists.ca/education-practice-resources/professional-development/medication-management/.
- Canadian Patient Safety Institute. 2016. [cited 2020 Jul 22]. Available from: https://www.patientsafetyinstitute.ca/en/Topic/Pages/Medication-Management.aspx.
- Guilcher SJT, Everall AC, Patel T, et al. “The strategies are the same, the problems may be different”: a qualitative study exploring the experiences of healthcare and service providers with medication therapy management for individuals with spinal cord injury/dysfunction. BMC Neurol. 2020;20(1):20.
- Gemperli A, Ronca E, Scheel-Sailer A, SwiSCI Study Group, et al. Health care utilization in persons with spinal cord injury: part 1-outpatient services. Spinal Cord. 2017;55(9):823–827.
- Kayyali R, Gebara SN, Hesso I, et al. Al-Haddad T and others. Shared decision making and experiences of patients with long-term conditions: has anything changed? BMC Health Serv Res. 2018;18(1):763.
- Deegan PE, Drake RE. Shared decision making and medication management in the recovery process. Psychiatr Serv. 2006;57(11):1636–1639.
- Fried TR, Tinetti ME, Iannone L. Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med. 2011;171(1):75–80.
- Zanini C, Rubinelli S, Lustenberger N, et al. Challenges to building and maintaining partnership in the prevention and treatment of pressure injuries in spinal cord injury: a qualitative study of health professionals' views. Swiss Med Wkly. 2019;149:w20086.
- Summer Meranius M, Engstrom G. Experience of self-management of medications among older people with multimorbidity. J Clin Nurs. 2015;24(19–20):2757–2764.
- Hogholen H, Storhaug A, Kvernrod K, et al. Use of medicines, adherence and attitudes to medicines among persons with chronic spinal cord injury. Spinal Cord. 2018;56(1):35–40.
- Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357.
- Patton MQ. Qualitative interviewing. Qual Res Eval Methods. 2002;3:344–347.
- Azungah T. Qualitative research: deductive and inductive approaches to data analysis. Qual Res J. 2018;18(4):383–400.
- Dierckx de Casterlé B, Gastmans C, Bryon E, et al. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–371.
- Thorne S, Kirkham SR, MacDonald-Emes J. Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health. 1997;20(2):169–177.
- Sibbald B. Rofecoxib (Vioxx) voluntarily withdrawn from market. CMAJ. 2004;171(9):1027–1028.
- Lofgren M, Norrbrink C. “But I know what works”-patients’ experience of spinal cord injury neuropathic pain management. Disabil Rehabil. 2012;34(25):2139–2147.
- Lee W, Noh Y, Kang H, et al. The mediatory role of medication adherence in improving patients' medication experience through patient-physician communication among older hypertensive patients. PPA. 2017;11:1119–1126.
- Levinson W, Lesser CS, Epstein RM. Developing physician communication skills for patient-centered care. Health Aff (Millwood)). 2010;29(7):1310–1318.
- Gardiner KM, Singleton JA, Sheridan J, et al. Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – a systematic review. PLoS One. 2019;14(5):e0216556.
- Parliament of Canada. Ottawa, Ontario, Canada; 2018. [cited 2020 Jul 22]. Available from: https://www.parl.ca/DocumentViewer/en/42-1/bill/c-45/royal-assent.
- Wallace GT, Parnes JE, Prince MA, et al. Associations between marijuana use patterns and recreational legislation changes in a large Colorado college student sample. Addict Res Theory. 2020;28(3):211–211.
- Cooper S, Nielsen S. Stigma and Social support in pharmaceutical opioid treatment populations: a scoping review. Int J Ment Health Addiction. 2017;15(2):452–469.
- Ballantyne JC, Mao J. Opioid Therapy for Chronic Pain. N Engl J Med. 2003;349(20):1943–1953.
- Islam MM, Poly TN, Walther BA, et al. Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018;30(12):1395–1405.
- Dubin RE, Kaplan A, Graves L, et al. Acknolweding stigma: its presence in patient care and medical education. Can Fam Physician. 2017;63(12):906–908.
- Bulls HW, Hoogland AI, Craig D, et al. Cancer and Opioids: Patient Experiences with Stigma (COPES) – a pilot study. J Pain Symptom Manage. 2019;57(4):816–819.
- Satterlund TD, Lee JP, Moore RS. Stigma among California's Medical Marijuana Patients. J Psychoactive Drugs. 2015;47(1):10–17.
- Berna F, Goritz AS, Mengin A, et al. Alternative or complementary attitudes toward alternative and complementary medicines. BMC Complement Altern Med. 2019;19(1):83.
- Breaden K, Collier A, Litster C, et al. Stigma and the in(visible) perspectives and expectations of home oxygen therapy among people with chronic breathlessness syndrome: a qualitative study. Palliat Med. 2019;33(1):82–90.
- Harries T, Rettie R, Gabe J. Shedding new light on the (in)compatibility of chronic disease management with everyday life - social practice theory, mobile technologies and the interwoven time-spaces of teenage life. Sociol Health Illn. 2019;41(7):1396–1409.
- Kaczorowski J, Patterson C, Arthur H, et al. Complementary therapy involvement of physicians: implications for practice and learning. Complement Ther Med. 2002;10(3):134–140.
- Olatunde S, Boon H, Hirschkorn K, et al. Roles and responsibilities of pharmacists with respect to natural health products: key informant interviews. Res Social Adm Pharm. 2010;6(1):63–69.
- Mehta DH, Gardiner PM, Phillips RS, et al. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med. 2008;14(10):1263–1269.
- Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women's views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006;6(1):40.
- Walji R, Boon H, Barnes J, et al. Consumers of natural health products: natural-born pharmacovigilantes? BMC Complement Altern Med. 2010;10(1):10.
- Buchman DZ, Ho A, Illes J. You present like a drug addict: patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Med. 2016;17(8):1394–1406.
- Kerse N, Buetow S, Mainous AG, et al. Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004;2(5):455–461.
- Meade M. Influence of provider behaviors on the health of individuals with spinal cord injury and disease: review and recommendations. Top Spinal Cord Inj Rehabil. 2011;17(2):70–80.